Biotech · Private company
Boston Pharmaceuticals
Track this companyFree. Adds Boston Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- BOS-589Phase 2 · Diarrhea-predominant Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- BOS161721Phase 2 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- BOS-356Phase 1 · Moderate to Severe Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- BOS161721Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- BOS172738Phase 1 · Advanced Nonhaematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 1 · Moderate to Severe Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne VulgarisPHASE1 · COMPLETED · started Nov 4, 2019ClinicalTrials.gov NCT04163263 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)PHASE2 · COMPLETED · started Jun 4, 2019ClinicalTrials.gov NCT03977155 · fetched Nov 12, 2026
- Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered TumorsPHASE1 · COMPLETED · started Dec 12, 2018ClinicalTrials.gov NCT03780517 · fetched Nov 12, 2026
- Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of CarePHASE1_PHASE2 · COMPLETED · started Jan 10, 2018ClinicalTrials.gov NCT03371251 · fetched Nov 12, 2026
- Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy SubjectsPHASE1 · COMPLETED · started Jan 1, 2017ClinicalTrials.gov NCT03036865 · fetched Nov 12, 2026